Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety、Immunogenicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00929331
What this trial is testing

Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years

Who this might be right for
Influenza, Human
GlaxoSmithKline 110
Early research (Phase 1)Study completedNCT02148328
What this trial is testing

Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults

Who this might be right for
Influenza
Crucell Holland BV 240
Large-scale testing (Phase 3)Study completedNCT00328107
What this trial is testing

Immunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults

Who this might be right for
Influenza
Protein Sciences Corporation 459
Testing effectiveness (Phase 2)Study completedNCT02531802
What this trial is testing

Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in Bangladesh

Who this might be right for
Escherichia Coli Diarrhea
PATH 475
Large-scale testing (Phase 3)Study completedNCT04927065
What this trial is testing

Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 5,161
Testing effectiveness (Phase 2)Study completedNCT00956202
What this trial is testing

Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 303
Early research (Phase 1)WithdrawnNCT01964937
What this trial is testing

Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Active Not RecruitingNCT05304351
What this trial is testing

Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older

Who this might be right for
Herpes ZosterShingles
Curevo Inc 1,516
Large-scale testing (Phase 3)Study completedNCT00539981
What this trial is testing

Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok

Who this might be right for
Influenza
Sanofi 4,648
Early research (Phase 1)Study completedNCT00344539
What this trial is testing

AMA1-C1/Alhydrogel + CpG 7909 for Malaria

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 75
Testing effectiveness (Phase 2)Study completedNCT00363077
What this trial is testing

Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate

Who this might be right for
Influenza
GlaxoSmithKline 150
Testing effectiveness (Phase 2)Study completedNCT04969601
What this trial is testing

Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings

Who this might be right for
Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris 76
Early research (Phase 1)Not Yet RecruitingNCT07326878
What this trial is testing

Phase I Clinical Trial of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine

Who this might be right for
Hand, Foot and Mouth Disease (HFMD)HFMDHand, Foot and Mouth Disease
Institute of Medical Biology, Chinese Academy of Medical Sciences 144
Testing effectiveness (Phase 2)Looking for participantsNCT06375915
What this trial is testing

Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy

Who this might be right for
Intrahepatic Cholangiocarcinoma
Francesco De Cobelli 33
Post-approval studies (Phase 4)Study completedNCT00310635
What this trial is testing

Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age

Who this might be right for
Meningococcal Infection
Novartis 241
Post-approval studies (Phase 4)Study completedNCT04384016
What this trial is testing

Safety and Immunogenicity of Skyvaricella Injection in Healthy Volunteer Vietnamese Children From 12 Months to 12 Years Old

Who this might be right for
Chickenpox
Vietnam Military Medical University 201
Testing effectiveness (Phase 2)Study completedNCT00397215
What this trial is testing

Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Adults Over 60 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 437
Testing effectiveness (Phase 2)Study completedNCT04742738
What this trial is testing

Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19)

Who this might be right for
COVID-19 (Healthy Volunteers)
SK Bioscience Co., Ltd. 260
Large-scale testing (Phase 3)Study completedNCT05642078
What this trial is testing

Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split Vaccine

Who this might be right for
Prevention of Influenza
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 2,550
Early research (Phase 1)Study completedNCT03038776
What this trial is testing

Recombinant H7 Hemagglutinin Influenza Vaccine Trial

Who this might be right for
Influenza, Avian
Vaxine Pty Ltd 150
Next Page